|
gptkbp:instanceOf
|
opioid metabolite
|
|
gptkbp:ATCCode
|
N02AA01
|
|
gptkbp:CASNumber
|
25316-41-2
|
|
gptkbp:chemicalFormula
|
C23H27NO9
|
|
gptkbp:detects
|
urine
|
|
gptkbp:drugClass
|
analgesic
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:hasGreaterPotencyThan
|
gptkb:morphine
|
|
gptkbp:hasSMILES
|
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5
|
|
gptkbp:hasUNII
|
1H4A1T6B2F
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Morphine-6-glucuronide
|
|
gptkbp:isActiveMetaboliteOf
|
gptkb:morphine
|
|
gptkbp:isFormedIn
|
liver
|
|
gptkbp:isLessAbleToCross
|
gptkb:blood-brain_barrier
|
|
gptkbp:isMorePotentIn
|
renal failure patients
|
|
gptkbp:IUPACName
|
gptkb:(5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol_6-β-D-glucopyranosiduronic_acid
|
|
gptkbp:legalStatus
|
not scheduled (varies by country)
|
|
gptkbp:metabolism
|
gptkb:morphine
|
|
gptkbp:molecularWeight
|
461.46 g/mol
|
|
gptkbp:producedBy
|
glucuronidation
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1201202
441369
|
|
gptkbp:routeOfAdministration
|
intravenous
epidural
intrathecal
|
|
gptkbp:sideEffect
|
nausea
pruritus
respiratory depression
sedation
|
|
gptkbp:usedFor
|
pain management
|
|
gptkbp:bfsParent
|
gptkb:M6G
|
|
gptkbp:bfsLayer
|
6
|